VVD-699
VVD-699 is a covalent RAS-PI3K inhibitor. VVD-699 covalently binds to cysteine 242 in the RAS binding domain of PI3K p110α, thereby blocking the ability of RAS to activate PI3K activity. VVD-699 is able to inhibit the growth of RAS-mutated and HER2-overexpressing tumors. VVD-699 can be used to study cancers associated with RAS mutations (e.g., H358 lung cancer cells, A549 cells, FaDu cells) [1].
Product Specifications
UNSPSC
12352005
Target
PI3K; Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
COC1=CC(C2=C(Cl)C=CC=C2)=C(S(N3CC[C@](C(N[C@@H](/C=C\S(C)(=O)=O)C)=O)(F)C[C@H]3C)(=O)=O)C=C1
Molecular Formula
C25H30ClFN2O6S2
Molecular Weight
573.10
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-173405/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[3055319-82-6]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Nuclear factor erythroid 2-related factor 2 (NFE2L2) Antibody (Biotin)